From: In silico profiling for secondary metabolites from Lepidium meyenii (maca) by the pharmacophore and ligand-shape-based joint approach
Targets related to CVD
Compounds
MAPK14
MA-1, 6, 9, 12, 21, 23, 24, 25, 36, 37, 38, 39, 40, 43
PPARα
MA-26
PPARγ
MA-1, 18, 24, 36
PPARδ
MA-4